This page has been fact checked by an experienced mesothelioma Patient Advocate. Sources of information are listed at the bottom of the article.
We make every attempt to keep our information accurate and up-to-date.
Please Contact Us with any questions or comments.
Dr. Dwight Owen is a medical oncologist at the James Cancer Hospital and a researcher at the Ohio State University Comprehensive Cancer Center in Columbus, Ohio. He specializes in treating patients with thoracic malignancies, including malignant pleural mesothelioma, lung cancer, and thymic cancers.
Dr. Owen says that what drove him into oncology was the human connection and the fact that it let him be his patients’ “home base.” He appreciates the ability to form long-term, special relationships with patients, even in the face of challenges.
Dr. Owen’s clinical focus is on using immunotherapy and other transformative treatments to overcome cancer’s ability to evade destruction by the immune system. He believes that his role is a combination of science, compassionate care, and education, and is excited about the promise of targeted treatments and other breakthroughs.
Education and Career
Dr. Owen attended medical school at the Trinity College Dublin School of Medicine and completed his internship and residency in Internal Medicine at SUNY Downstate Medical Center in Brooklyn, New York. He then served as chief resident in Internal Medicine at Memorial Sloan-Kettering Cancer Center in New York and served as chief fellow in Hematology and Oncology at Ohio State University Wexner Medical Center. He also earned his Master of Science at The Ohio State University Graduate School.
While still completing his fellowship at Ohio State, Dr. Owen expanded on the facility’s system-based education curriculum and led the development of a Quality Improvement Program to optimize procedure training. In addition to caring for patients, Dr. Owen is an Assistant Professor of Internal Medicine in the Division of Medical Oncology and a member of the Translational Therapeutics Program at the Ohio State University Comprehensive Cancer Center — James, where he works on developing ways to better identify patients with thoracic cancers who will most benefit from the use of immunotherapy. He is also the thoracic malignancies Associate Editor for medical oncology at theMednet.
Dr. Owen’s research focuses on understanding mechanisms of secondary resistance to targeted and immune-based therapies. He has been published in the Journal of Clinical Oncology, Journal of Thoracic Disease, and Journal of Oncology Practice. He was the recipient of the Conquer Cancer Foundation’s Young Investigator Award bestowed by the American Society of Clinical Oncology.Get Your FREE Mesothelioma Packet
Written by Terri Oppenheimer
Terri Oppenheimer has been writing about mesothelioma and asbestos topics for over ten years. She has a degree in English from the College of William and Mary. Terri’s experience as the head writer of our Mesothelioma.net news blog gives her a wealth of knowledge which she brings to all Mesothelioma.net articles she authors.
Page Edited by Patient Advocate Dave Foster
Dave has been a mesothelioma Patient Advocate for over 10 years. He consistently attends all major national and international mesothelioma meetings. In doing so, he is able to stay on top of the latest treatments, clinical trials, and research results. He also personally meets with mesothelioma patients and their families and connects them with the best medical specialists and legal representatives available.